Martin Williams Email & Phone Number
Who is Martin Williams? Overview
A concise factual answer block for searchers comparing this professional profile.
Martin Williams is listed as CEO and Founder at SYTE.bio, a with 11 employees, based in Argentina. AeroLeads shows a matched LinkedIn profile for Martin Williams.
Martin Williams previously worked as CEO & Founder at Syte.Bio and Strategic Consultant at Bio Strategy Advisors, Llc. Martin Williams holds Bachelor'S Degree, Biotechnology from Uade.
Email format at SYTE.bio
This section adds company-level context without repeating Martin Williams's masked contact details.
Review company-level records connected to Martin Williams before choosing the right outreach path.
About Martin Williams
I have over 15 years of experience in Biotechnology and Synthetic Biology, with a PhD in Synthetic Biology, specialized in viral and non-viral vaccines, cell and gene therapies development, and cutting-edge nucleic acid-based technologies. As the founder and CEO of SYTE.bio, a Synthetic Biology company focused on advancing next-generation DNA and RNA-based vaccines and therapies for both human and veterinary medicine, I lead a dedicated team driving innovation in the field. My sharp focus on execution has enabled me to deliver impressive results swiftly.In addition to my role at SYTE.bio, I am the CEO and Founder of Healix Instruments, a medical device company, and previously served as Interim Chief Scientific Officer for Athergen, a Boston-based company specializing in cell reprogramming technology using miRNA. My strategic insights also extend further, as I am the founder and principal of BioConsulting Group, a global consulting firm specializing in biotechnology and synthetic biology. I also lend my expertise as a Strategic Consultant at BioStrategy Advisors LLC, a consultancy firm based in Boston. Over the years, I’ve been instrumental in assessing the scientific value of technologies, guiding research and development from discovery through pre-clinical and clinical stages, and advising start-up founders on therapies and device development, and pipeline prioritization.I also have the honor of serving as the founder and President of the Argentinean Synthetic Biology Association, the first organization of its kind in Latin America. Additionally, I am a professor of Genetic Engineering at Universidad Favaloro in Argentina. My diverse background in synthetic biology includes work on cancer treatments including melanoma and sarcoma, involving DNA, RNA, oncolytic viruses, insect and bacterial engineered viruses; as well as diseases such as Type 1 and Type 2 Diabetes, and Anemia. I’ve also contributed to the development of vaccines for rabies, dengue, and hantavirus.My expertise spans across Biotechnology, Molecular Biology, Synthetic Biology, Genetic Engineering, Bioinformatics, and the development of viral and non-viral vaccines and gene therapies. I am also skilled in patent analysis and writing, having been granted patents on groundbreaking technologies, as well as Management, Corporate Strategy, Business Development and Agreements. My mission is to drive innovation in healthcare by creating transformative medical solutions and offering strategic advice that fosters the growth of biotechnology projects.
Listed skills include Microsoft Office, Microsoft Excel, Cultivos Celulares, Microsoft Word, and 27 others.
Martin Williams's current company
Company context helps verify the profile and gives searchers a useful next step.
Martin Williams work experience
A career timeline built from the work history available for this profile.
Ceo & Founder
Current
Strategic Consultant
Current
Member & Investor
CurrentThe Longevity Investor Network is an initiative to bring together investors and promising biotech and medtech startups working on next-generation technologies to treat diseases of aging and address other longevity-related issues.
President
Current
Founder & Principal
Current
Genetic Engineering Professor
Current
Interim Chief Scientific Officer
Phd Researcher
Development of a novel viral vector system for mammalian gene therapy based on M13 phage.
Founder & Ceo
Synthetic Biology Laboratory
Martin Williams education
Bachelor'S Degree, Biotechnology
Degree Thesis: Development Of A Viral Gene Therapy For Cancer Treatment, Genetic Engineering - Synthetic Biology
Pharmaceutical Biotechnology, Biotecnología
Phd, Synthetic Biology
Frequently asked questions about Martin Williams
Quick answers generated from the profile data available on this page.
What company does Martin Williams work for?
Martin Williams works for SYTE.bio.
What is Martin Williams's role at SYTE.bio?
Martin Williams is listed as CEO and Founder at SYTE.bio.
Where is Martin Williams based?
Martin Williams is based in Argentina while working with SYTE.bio.
What companies has Martin Williams worked for?
Martin Williams has worked for Syte.Bio, Bio Strategy Advisors, Llc, Lifespan.Io (Lifespan Extension Advocacy Foundation), Asociación Argentina De Biología Sintética, and Bioconsulting Group.
How can I contact Martin Williams?
You can use AeroLeads to view verified contact signals for Martin Williams at SYTE.bio, including work email, phone, and LinkedIn data when available.
What schools did Martin Williams attend?
Martin Williams holds Bachelor'S Degree, Biotechnology from Uade.
What skills is Martin Williams known for?
Martin Williams is listed with skills including Microsoft Office, Microsoft Excel, Cultivos Celulares, Microsoft Word, Microsoft Powerpoint, Liderazgo De Equipos, English, and Ciencias.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial